Polish multicenter study on diabetes epidemiology (PMSDE) - 1998-2000;Polskie wieloośrodkowe badania nad epidemiologia̧ cukrzycy (PWBEC) - 1998-2000

Polskie Archiwum Medycyny Wewnetrznej

Volumn 106, Issue 3, 2001, Pages 751-758

  Szybiński, Zbigniew ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Diabetes economy; Diabetes epidemiology; Intervention models; Risk factors

Indexed keywords

ADULT; AGED; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; ECONOMICS; EDITORIAL; FEMALE; HEALTH EDUCATION; HEALTH PROMOTION; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLAND; PREVALENCE; PRIMARY HEALTH CARE; RISK FACTOR; SELF CARE;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HEALTH EDUCATION; HEALTH PROMOTION; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES; POLAND; PREVALENCE; PRIMARY HEALTH CARE; RISK FACTORS; SELF CARE;

EID: 0035468689     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. King H., Rewers M.: WHO Ad Hoc Diabetes Reporting Group.: Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care, 1993, 16, 157.
2. Zimmet P.Z., McCarty D.J., deCourten M.P.: The global epidemiology of non-insulindependent diabetes mellitus and the metabolic syndrome. J. Diab. Comp., 1997, 11, 60.
3. King H., Aubert R.E., Herman W.H.: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care, 1998, 21, 1414.
4. Szybiński Z, Czyżyk A., Wa̧sik R. i wsp.: Epidemiology of insulin-dependent and non-insulin dependent diabetes mellitus in Poland. Diab. Nutr. Metab., 1993, 6, 339.
5. WHO Europe IDF. Diabetes Care and Research in Europe: the St. Vincent Declaration. Diabet. Med., 1990, 7, 260.
6. Report of Expert committee on the diagnosis and classification of diabetes mellitus, Diabetes Care, 1997, 20, 1183.
7. National Diabetes Data Group, Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance, Diabetes, 1979, 28, 1039.
8. WHO Diabetes Mellitus: Report of a WHO Study Group, Technical Report Series 727, Geneva WHO 1985.
9. The DECODE Study Group, on behalf of the Diabetes Epidemiology Group. Glucose Tolerance and Cardiovascular Mortality. Comparison of Fasting and 2-Hour Diagnostic Criteria. Arch. Intern. Med., 2001, 161, 397.
10. Reaven G.M.: Banting lecture 1988: Role of insulin resistance in human disease. Diabetes, 1988, 37, 1595.
11. Reaven G.M.: Syndrome X in: Diabetes Mellitus, Carbohydrate Metabolism, and Lipid Disorders, 2001, 68, 954.
12. Stern M.P.: The Insulin Resistance Syndrome, International Textbook of Diabetes Mellitus, Second Edition, John Wiley & Sons Ltd, 1997, 255.
13. Modan M., Halkin H., Almog S. i wsp.: Hyperinsulinemia: a link between hypertension, obesity, and glucose intolerance. J. Clin. Invest., 1985, 75, 809.
14. Charles M.A., Fantbonne A., Thibult N., Warnet J.M., Rosselin G.E., Eschwege E.: Risk factors for NIDDM in white population, Paris Prospective Study. Diabetes, 1991, 40, 796.
15. Muscelli E., Natali A., Bianchi S. i wsp.: Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am. J. Hypertens., 9, 1996, 746.
16. Zavaroni I., Coruzzi P., Bonini L. i wsp.: Association between salt sensitivity and insulin concentrations in patients with hypertension. Am. J. Hypertens., 8, 1995, 855.
17. Ferrannini E., Buzzigoli G., Bonadona R. i wsp.: Insulin resistance in essential hypertension, New Engl. J. Med., 1987, 317, 350.
18. Olefsky J.M., Farquhar J.W., Reawen G.M.: Reappraisal of the role of insulin in hypertriglyceridemia, Am. J. Med., 1974, 57, 551.
19. Reaven G.M., Chen Y-DI., Jeppesen J. i wsp.: Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J. Clin. Invest., 1993, 92, 141.
20. Asplund-Carlson A., Hamsten A., Wiman B., Carlson L.A.: Relationship between plasma plasminogenactivator inhibitor-1 and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men. Diabetologia, 1993, 36, 817.
21. Landin K., Stigendal L., Eriksson E., Krotkiewski M., Risberg B., Tengborn L., Smith U.: Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor 1. Metabolism, 1990, 39, 1044.
22. Juhan-Vague I., Vague P.: Hypofibrinolysis and insulin resistance. Diabete Metab., 1991, (suppl. 2), 96.
23. Stern M.P., Haffner S.M.: Body fat distribution and hyperinsulinemias risk factors for diabetes and cardiovascular disease. Arteriosclerosis, 1986, 6, 123.
24. Stout R.W.: Insulin and atheroma, 20-year perspective, Diabetes Care, 1990, 13, 631.
25. Czyżyk A., Szczepanik Z.: Diabetes Mellitus and Cancer, Europ. J. Int. Med., 2000, 11, 245.
26. Szybiński Z., Sieradzki J., Mruk K. i wsp.: Wpływ diety redukcyjnej na tolerancjȩ wȩglowodanowa̧ i postȩpowanie lecznicze cukrzycy skojarzonej z otylościa̧. Pol. Arch. Med. Wewn., 1978, 5, 423.
27. Friedman J.E., Dohm G.L., Leggett-Frazier N.: Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4, J. Clin. Invest., 1992, 89, 701.
28. Rekomendacje Kliniczne 1998. Miȩdzynarodowa Komisja Specjalna ds. Prewencji Choroby Niedokrwiennej. Czynniki Ryzyka 1998, 4, 22.